Industry concerns rise as China steps up procurement of low-cost essential drugs
This article was originally published in Scrip
Executive Summary
The Guangdong provincial government in China is working on the final version of an essential drugs (ED) procurement programme to secure the supply of such products for the region's local community clinics. But multinationals are worried that a focus on low prices in line with a similar trial programme in another province means they will be unsuccessful in the bidding.